Admission Date:  [**2182-6-19**]              Discharge Date:   [**2182-6-22**]  Date of Birth:  [**2123-10-15**]             Sex:   F  Service: NEUROSURGERY  Allergies: Fosphenytoin / Codeine / Morphine  Attending:[**First Name3 (LF) 1835**] Chief Complaint: metastatic breast cancer  Major Surgical or Invasive Procedure: left temporal craniotomy   History of Present Illness: 58-year-old female with a history of metastatic breast carcinoma with metastases to the brain.
The patient had previously undergone radiotherapy in [**2178-5-23**] with stereotactic radiosurgery performed in [**10-25**].
She was followed up routinely with an MRI scan on [**2182-5-24**] and remains on an HKI-272 protocol for treatment.
Biopsy at that time revealed an infiltrating ductal carcinoma and the patient underwent a mastectomy (tumor size was 4.5 cm, ER positive, and Her2neu positive).
-approximately 14 months after mastectomy, underwent six cycles of CMF therapy.
-[**2174**]: left hip met -initiated care w/ Dr. [**Last Name (STitle) **] in [**2175**]; XRT and herceptin -Navelbine and Herceptin -Herceptin and carboplatin [**1-27**] -now with brain and rib mets -has been on multiple protocols -currently on HK1-272 04-266 trial with several recent dose reductions, Zometa last received on [**2182-4-16**] -seen in ED on [**2182-3-21**] with rib pain, ruled out for PE, thought to be due to known metastases.
Physical Exam: awake, alert, oriented x3 afebrile with vital signs stable PERRL, EOMI bilaterally rrr, CTAB Full motor strength in all extremities Full sensory exam throughout  Pertinent Results: [**2182-6-19**] 02:33PM   PT-12.1 PTT-52.0* INR(PT)-1.0 [**2182-6-19**] 02:33PM   PLT COUNT-223 [**2182-6-19**] 03:40PM   GLUCOSE-79 LACTATE-0.9 NA+-132* K+-3.1* CL--100 [**2182-6-19**] 04:33PM   GLUCOSE-102 LACTATE-0.8 NA+-135 K+-3.1* CL--100 [**2182-6-19**] 06:30PM   PT-12.0 PTT-24.7 INR(PT)-1.0 [**2182-6-19**] 06:30PM   PLT COUNT-232 [**2182-6-19**] 06:30PM   CALCIUM-8.5 PHOSPHATE-3.2 MAGNESIUM-1.9  Brief Hospital Course: The patient presented to the hospital for surgery on [**2182-6-19**].
She underwent a left temporal craniotomy for removal of her mass.
She then stayed in the PACU overnight as standard for craniotomy patients.
She continued to do well on the floor.
Her foley catheter was discontinued after she was moved to the regular floor.
Medications on Admission: advair, aranesp, coumadin, flonase, [**Date Range **], lamictal, lipitor, lorazepam, magnesium sulfate, nexium, singulair, zyrtec, HKL-272 (trial drug)  Discharge Medications: 1.
Insulin Regular Human 100 unit/mL Solution Sig: One (1) unit Injection ASDIR (AS DIRECTED): see sliding scale.
Lamotrigine 100 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Levetiracetam 250 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Cetirizine 10 mg Tablet Sig: One (1) Tablet PO QD ().
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Fluticasone-Salmeterol 100-50 mcg/Dose Disk with Device Sig: One (1) puff Inhalation [**Hospital1 **] (2 times a day).
Multivitamin     Capsule Sig: One (1) Cap PO DAILY (Daily).
Montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Lorazepam 0.5 mg Tablet Sig: 0.5 Tablet PO Q4-6H (every 4 to 6 hours) as needed.
Atorvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Chlorpheniramine-Hydrocodone 8-10 mg/5 mL Suspension, Sust.
Fluticasone 50 mcg/Actuation Aerosol, Spray Sig: Two (2) Spray Nasal QAM (once a day (in the morning)).
Magnesium Oxide 140 mg Capsule Sig: Two (2) Capsule PO HS (at bedtime).
Oxycodone-Acetaminophen 5-325 mg Tablet Sig: One (1) Tablet PO Q4-6H (every 4 to 6 hours) as needed.
Trazodone 50 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed.
Dexamethasone 4 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours): wean as directed.
Disp:*90 Tablet(s)* Refills:*0*   Discharge Disposition: Home With Service  Facility: [**Company 1519**]  Discharge Diagnosis: radiation necrosis of brain   Discharge Condition: stable, awake and alert, tolerating POs   Discharge Instructions: Please f/u with Nsurg in [**3-28**] weeks.
